Title: Combination effects of AHR agonists and Wnt/β-catenin modulators in zebrafish embryos: Implications for physiological and toxicological AHR functions.
Journal: Toxicology and applied pharmacology20150415
Title: A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS.
Journal: Cell stem cell20130606
Title: Roles of glycogen synthase kinase 3 in Alzheimer's disease.
Journal: Current Alzheimer research20120901
Title: Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience20120523
Title: Inhibition of Gsk3β activity improves β-cell function in c-KitWv/+ male mice.
Journal: Laboratory investigation; a journal of technical methods and pathology20120401
Title: Neuroprotective effects of the beta-catenin stabilization in an oxygen- and glucose-deprived human neural progenitor cell culture system.
Journal: International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience20110801
Title: Regulation of serotonin 1B receptor by glycogen synthase kinase-3.
Journal: Molecular pharmacology20091201
Title: Reduced amyloidogenic processing of the amyloid beta-protein precursor by the small-molecule Differentiation Inducing Factor-1.
Journal: Cellular signalling20090401
Title: Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity.
Journal: Cellular signalling20090201
Title: Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells.
Journal: The Journal of biological chemistry20081107
Title: Epidermal growth factor-stimulated extravillous cytotrophoblast motility is mediated by the activation of PI3-K, Akt and both p38 and p42/44 mitogen-activated protein kinases.
Journal: Human reproduction (Oxford, England)20080801
Title: 9-cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replication.
Journal: Journal of medicinal chemistry20080410
Title: Glycogen synthase kinases 3alpha and 3beta in cardiac myocytes: regulation and consequences of their inhibition.
Journal: Cellular signalling20080101
Title: New thiophene analogues of kenpaullone: synthesis and biological evaluation in breast cancer cells.
Journal: European journal of medicinal chemistry20050801
Title: Epoxide-containing side chains enhance antiproliferative activity of paullones.
Journal: European journal of medicinal chemistry20050701
Title: GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons.
Journal: Journal of cell science20041115
Title: 1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta.
Journal: Bioorganic & medicinal chemistry letters20040119
Title: The specificities of protein kinase inhibitors: an update.
Journal: The Biochemical journal20030401
Title: Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
Journal: Diabetes20000201
Title: Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice.
Journal: Diabetes19990801
Title: Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases.
Journal: Cancer research19990601
Title: Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.
Journal: Proceedings of the National Academy of Sciences of the United States of America19930815
Title: Kunick C, et al. 1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta. Bioorg Med Chem Lett. 2004 Jan 19;14(2):413-6.
